FinanceHospitals, Insurers at Odds Over Surprise Medical Bills Legislation
While insurers and hospitals alike see balance billing as a problem, they disagree on its causes and solutions.
FinanceMetro Areas With High Prices Have Low Utilization Rates
A five-year study analyzed the healthcare prices and utilization rates across 112 metropolitan areas.
FinanceThis Time When My Water Breaks, Take Me To A Hospital Without Surprise Bills
Researchers sought to determine how pregnant women who dealt with surprise medical bills from their first delivery approached decisions about...
Finance4 Takeaways From Pharma Testimony at Senate Drug Pricing Hearing
Major industry leaders defended themselves against accusations of immoral price hikes, telling senators that they intend to provide patients with...
FinancePrice Transparency Leader Pushes for Cost Estimate Accuracy
UCHealth continues to improve its cost estimator tool to ensure the highest degree of accuracy and avoid surprising patients with...
FinanceWhat to Expect at the Senate Drug Pricing Hearing
Tuesday's highly anticipated Senate Finance Committee hearing on drug pricing will feature the CEOs of all seven major drug manufacturers.
FinanceHospitals Give Congress 8-Point Checklist for 'Surprise Bills' Legislation
The joint letter comes two months after major payer groups outlined a framework of their own, as the industry debates...
FinanceRising Prices Lead to All-Time High Healthcare Spending
Americans are paying more for the same amount of healthcare, according to a new report from HCCI.
FinanceUCHealth's Revenue Cycle Takes Price Transparency to Next Level
CMS Administrator Seema Verma recently named UCHealth as one of the exemplars providing price transparency that goes above CMS requirements.
FinanceDrug Pricing Proposals Put Pharma at Greater Financial Risk
Efforts at the state and federal level to reduce prescription drug prices pose a financial risk for pharmaceutical companies, according...
StrategyPBMs Launch Counteroffensive as Trump Administration Floats Plan to Eliminate 'Middleman' Drug Rebates
OnYourRxSide campaign targets critics who say safe harbors allow PBMs to flourish as self-serving middleman leveraging an arcane regulatory framework...
FinanceHHS Proposal Could Kill PBM Rebates: Some Pleased, Others Concerned
The proposal would end safe-harbor protections for the rebates drug manufacturers pay to PBMs and add safe-harbor protections for drug...